Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Neal Katz

Neal Katz

Director of Solutions Marketing

Connect with Neal Katz on LinkedIn
Website:

About the author: Neal Katz has over 20 years of experience bringing information technology solutions to market. As Senior Manager of Solutions Marketing at Elsevier, Neal has been responsible for assembling information solutions for life science companies, as well as academic and government institutions. He has developed similar solutions and programs at companies like AT&T and Intel.

Posts by Neal Katz

The Importance of Literature on Medical Device Development and Post Market Surveillance

Posted on November 13th, 2015 in Chemistry

Before the ideation and creation of a novel prototype device β€” or the establishment of a new purpose for an existing one β€” medical device manufacturers must be confident that the device will serve a real need in the market. They must also establish that the device has unique value and will be safe and effective. (more…)

Best Practices for Post-Market Surveillance Processes

Posted on November 13th, 2015 in Pharmacovigilance

Donna Sees, an Information Consultant with PharmIntell Consulting, has been a librarian in the medical field for more than 10 years. In this article, she discusses post-market surveillance processes and best practices for medical device companies.

Learn how PharmIntell Consulting took advantage of QUOSA.

Pharmacovigilance: Rethinking Literature Monitoring and Review

Posted on October 27th, 2015 in Pharmacovigilance

Pharmacovigilance is defined as β€œthe science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems.” Under that umbrella, government agencies in the United States, the European Union and other parts of the world have developed diverse and increasingly complex regulatory requirements. (more…)

  1. 1
  2. …
  3. 3
  4. 4
  5. 5